Peptide record

TPDB10820

Antibacterial Toxicity standard
26 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10820
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 26-aa standard-residue multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KWKSFLKTFKAAVKTVLHTALKAISS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C138H227N35O33
RNDCEQGMPY
K
2904.54
11.21
7
0
13
+6
0.48
0.196
97.69
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
5500
1.89
6
Residue Composition
number
4
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
1
H
1
I
3
L
6
K
0
M
2
F
0
P
3
S
3
T
1
W
0
Y
2
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 1 I: 1 L: 3 K: 6 M: 0 F: 2 P: 0 S: 3 T: 3 W: 1 Y: 0 V: 2
Chemical Descriptors
26 reviewed residue count
C138H227N35O33 sequence-only estimate (linear, free termini)
2904.54 sequence-only estimate (linear, free termini)
11.21 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
0.48 sequence-only estimate (linear, free termini)
0.196 sequence-only estimate (linear, free termini)
Evidence Records 2 records
Evidence 1 Activity

Activity

0% Hemolysis
Toxicity
15.6 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 15.6 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. | J Biol Chem | 2005
Evidence 2 Activity

Activity

MHC
Toxicity
15.6 µg/mL
Hemolytic
Hemolytic_activity: [Ref.15677462]MHC=15.6 µg/ml against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
J Biol Chem. 2005 Apr 1 280(13):12316-29.